Document:

Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase
Agreement (this “Agreement”) is dated as of April 5, 2021, between China Green Agriculture, Inc., a Nevada
corporation (the “Company”), and investors (the “Purchaser”).

 

WHEREAS, subject to
the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
(the “Securities Act”), the Company desires to issue and sell to the Purchaser, and the Purchaser desires to
purchase from the Company, securities of the Company as more fully described in this Agreement.

 

NOW, THEREFORE, IN
CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:

 

ARTICLE I.

DEFINITIONS

 

1.1 Definitions.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the
meanings set forth in this Section 1.1:

 

“Acquiring Person” shall
have the meaning ascribed to such term in Section 4.5.

 

“Action” shall have the
meaning ascribed to such term in Section 3.1(j).

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Board of Directors”
means the board of directors of the Company.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close.

 

“Closing” shall have
the meaning ascribed to such term in Section 2.1(a).

 

“Commission” means the
United States Securities and Exchange Commission.

 

“Common Stock”
means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.

 

“Common Stock
Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.

 

“Disclosure Schedules”
means the Disclosure Schedules of the Company delivered concurrently herewith.

 

“Evaluation Date” shall
have the meaning ascribed to such term in Section 3.1(o).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Closing Date”
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto
pursuant to Section 2.2(a), and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount
as to the Closing and (ii) the Company’s obligations to deliver the Securities as to the Closing, in each case, have been
satisfied or waived.

 

“Closing Shares” shall
have the meaning ascribed to such term in Section 2.1(a).

 

“Closing Subscription
Amount” equals the multiplication product of the Closing Shares and Per Share Purchase Price in United States dollars
and in immediately available funds.

 

     

     

    

 

“GAAP” shall have the
meaning ascribed to such term in Section 3.1(h).

 

“Liens”
means a material lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

“Material Adverse Effect”
shall have the meaning assigned to such term in Section 3.1(b).

 

“Per Share
Purchase Price” equals seven even in United States Dollars, subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.

 

“Regulation S”
means Regulation S promulgated by the Commission pursuant to the Securities Act, as such Regulation may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Regulation.

 

“Required Approvals”
shall have the meaning ascribed to such term in Section 3.1(e).

 

“Rule 144”
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.

 

“SEC Reports” shall have
the meaning ascribed to such term in Section 3.1(h).

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Short Sales”
means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to
include the location and/or reservation of borrowable shares of Common Stock).

 

“Subscription Amount”
means the Closing Subscription Amount.

 

“Subsidiary”
means any direct or indirect subsidiary of the Company formed or acquired.

 

“Trading Day”
means a day on which the principal Trading Market is open for trading.

 

“Trading Market”
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question:
the NYSE MKT, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the OTC
Bulletin Board (or any successors to any of the foregoing).

 

“Transaction
Documents” means this Agreement, and any other documents or agreements executed by the Company and/or the Purchaser in
connection with the transactions contemplated hereunder.

 

“Transfer
Agent” means Continental Stock Transfer & Trust Company, the current transfer agent of the Company, with a mailing
address of 1 State Street, 30th Floor, New York, NY 10004-1561, and any successor transfer agent of the Company.

 

    2

     

    

 

ARTICLE II.

PURCHASE AND SALE

 

2.1 Closing.
On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchaser
agree to purchase shares of Common Stock (the “Closing Shares”). The Purchaser shall deliver to the Company,
via wire transfer or a certified check, immediately available funds equal to the Closing Subscription Amount and the Company shall
deliver to the Purchaser the Closing Shares within three Trading Days of the Closing Date, and the Company and the Purchaser shall
deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions
set forth in Sections 2.2 and 2.3, but no later than three Trading Days subsequent to the Closing date, the Closing shall occur
at the location as the parties shall mutually agree or remotely by exchange of Closing documents.

 

2.2 Deliveries.

 

(a) On
or prior to each Closing, the Company shall deliver or cause to be delivered to the Purchaser the following:

 

(i) as to each Closing, a copy
of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver a certificate evidencing the Shares,
registered in the name of the Purchaser;

 

(b) On
or prior to each Closing, the Purchaser shall deliver or cause to be delivered to the Company, as to the Closing, the Closing Subscription
Amount, by wire transfer of immediately available funds to the account specified in writing by the Company;

 

2.3 Closing Conditions.

 

(a) The
obligations of the Company hereunder in connection with each Closing are subject to the following conditions being met:

 

(i) all
obligations, covenants and agreements of the Purchaser required to be performed at or prior to the applicable Closing shall have
been performed; and

 

(ii) as
to the Closing, the Company and the Purchaser shall have agreed on the use of proceeds from the transactions contemplated hereunder;
and

 

(iii) the
delivery by the Purchaser of the items set forth in Section 2.2(b) of this Agreement.

 

(b) The
obligations of the Purchaser hereunder in connection with each applicable Closing are subject to the following conditions being
met:

 

(i) all
obligations, covenants and agreements of the Company required to be performed at or prior to the applicable Closing shall have
been performed;

 

(ii) the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

 

(iii) the
Company is listed as a public company on, and the shares of Common Stock are tradable over the NYSE;

 

(v) as to
the Closing, the Company and the Purchaser shall have agreed on the use of proceeds from the transactions contemplated hereunder;
and

 

(vi) On
the date of the applicable Closing, trading in the Common Stock shall not have been suspended by the Commission or the Company’s
principal Trading Market, and, on the date of the applicable Closing, trading in securities generally as reported by Bloomberg
L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are
reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national
or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in
each case, in the reasonable judgment of the Purchaser, makes it impracticable or inadvisable to purchase the Securities at the
applicable Closing.

 

    3

     

    

  

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

 

3.1 Representations
and Warranties of the Company. Except as set forth in the Disclosure Schedules and the SEC Reports, which Disclosure Schedules
shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained
in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties
to the Purchaser:

 

(a) Subsidiaries.
All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid and non-assessable. If the Company has no subsidiaries,
all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

 

(b) Organization
and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company
nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity
or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, or business,
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform
in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material
Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.

 

(c) Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by
it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company
and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith
or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the
terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.

 

(d) No
Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate
or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default
(or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any
of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing
a Company or Subsidiary debt or otherwise) to which the Company or any Subsidiary is a party or by which any property or asset
of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a
violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such
as could not have or would not reasonably be expected to result in a Material Adverse Effect.

 

    4

     

    

 

(e) Filings,
Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice
to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)
the filings required pursuant to Section 4.4 of this Agreement, (ii) application(s) to each applicable Trading Market for the additional
listing of the Shares for trading thereon in the time and manner required thereby, and (iii) such filings as are required to be
made under applicable state securities laws (collectively, the “Required Approvals”).

 

(f) Issuance
of the Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other
than restrictions on transfer provided by the Transaction Documents. The Company has reserved from its duly authorized capital
stock the maximum number of shares of Common Stock issuable pursuant to this Agreement.

 

(g) Capitalization.
As of February 10, 2021, the company has 6,350,129 shares issued and outstanding. Since February 10, 2021, the Company has not
issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise
of employee stock options under the Company’s stock option plans, the issuance of shares of Common Stock to employees pursuant
to the Company’s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents
outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first
refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the
Transaction Documents. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully
paid and nonassessable, have been issued in material compliance with all federal and state securities laws, and none of such outstanding
shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval
or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities.
There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company’s capital
stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders.

 

(h) SEC
Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof,
for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such
material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein being collectively
referred to herein as the “SEC Reports”) on a timely basis or has received a valid extension of such time of
filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC
Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and
none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading. The Company is an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the
Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company
and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods
then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

    5

     

    

  

(i) Material
Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements included
within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof, (i) there has
been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect,
(ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses
incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the
Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not
altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property
to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v)
the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock
option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except
for the issuance of the Securities contemplated by this Agreement or as set forth in the SEC Reports, no event, liability, fact,
circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the
Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial condition that would be
required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made
that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.

 

(j) Litigation.
Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local
or foreign) (collectively, an “Action”) which (i) adversely affects or challenges the legality, validity or
enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have
or reasonably be expected to result in a Material Adverse Effect. There has not been, and to the knowledge of the Company, there
is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or
officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

(k) Labor
Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of
the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’
employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or
any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure
or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant
in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of
its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance
with all applicable laws and regulations relating to employment and employment practices, terms and conditions of employment and
wages and hours, except where the failure to be in compliance would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect.

 

(l) Compliance.
Except as set forth in the SEC Reports, neither the Company nor any Subsidiary: (i) is in default under or in violation of (and
no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company
or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that
it is in violation of, any indenture, loan or credit agreement or any other material agreement or instrument to which it is a party
or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation
of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation
of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal,
state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and
employment and labor matters, except in each case as would not have or reasonably be expected to result in a Material Adverse Effect.

 

    6

     

    

  

(m) Title
to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not
materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens
for the payment of federal, state or other taxes, for which appropriate reserves have been made in accordance with GAAP and, the
payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company
and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries
are in compliance in all material respects.

 

(n) Insurance.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and
in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither the
Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without
a significant increase in cost.

 

(o) Internal
Accounting Controls. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to
ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. The Company’s
certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries
as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the “Evaluation
Date”). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the
certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation
Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined
in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect,
the internal control over financial reporting of the Company and its Subsidiaries.

 

(p) Fees.
No brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial
advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by the Transaction Documents. The Purchaser shall have no obligation with respect to any fees or with respect to any claims made
by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions
contemplated by the Transaction Documents.

 

(q) Private
Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, no registration
under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.

 

(r) No
General Solicitation. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers
and certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.

 

(s) Listing
and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the
Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth in the SEC Reports, the Company is in compliance with such listing and maintenance requirements.
The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing
corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing
corporation) in connection with such electronic transfer.

 

    7

     

    

 

(t) Application
of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company’s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable to the Purchaser as a result of the Purchaser and
the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation
as a result of the Company’s issuance of the Securities and the Purchaser’s ownership of the Securities.

 

(u) Disclosure.
All of the disclosure furnished by or on behalf of the Company to the Purchaser regarding the Company and its Subsidiaries, their
respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and
correct in all material respects and does not contain any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.

 

(v) Accountants.
The Company’s current accounting firm is SS Accounting & Auditing, Inc. To the knowledge and belief of the Company, such
accounting firm (i) is a registered public accounting firm as required by the Exchange Act, (ii) had expressed its opinion with
respect to the financial statements included in the Company’s Annual Report for the fiscal year ending June 30, 2020 and
(iii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report for
the fiscal year ending June 30, 2021.

 

3.2 Representations and Warranties of
the Purchaser. The Purchaser hereby represents and warrants as of the date hereof and as of each Closing to the Company as
follows (unless as of a specific date therein):

 

(a) Organization;
Authority. The Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability
company or similar power and authority to enter into and to consummate the transactions contemplated by this Agreement and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and performance by the Purchaser
of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate, partnership, limited liability
company or similar action, as applicable, on the part of the Purchaser. Each Transaction Document to which it is a party has been
duly executed by the Purchaser, and when delivered by the Purchaser in accordance with the terms hereof, will constitute the valid
and legally binding obligation of the Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by
general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by
applicable law.

 

(b) Own
Account. The Purchaser understands that the Securities are “restricted securities” and have not been registered
under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account
and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act
or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities
Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to
distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities
law (this representation and warranty not limiting the Purchaser’s right to sell the Securities pursuant to a registration
statement or otherwise in compliance with applicable federal and state securities laws). The Purchaser is acquiring the Securities
hereunder in the ordinary course of its business.

 

(c) Purchaser
Status. At the time the Purchaser was offered the Securities, it was, and as of the date hereof it is, either: (i) an “accredited
investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified
institutional buyer” as defined in Rule 144A(a) under the Securities Act; or (iii) non-US residents, as permitted by Regulation
S under the Securities Act.

 

(d) Experience
of the Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk
of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

(e) General
Solicitation. The Purchaser is not, to its knowledge, purchasing the Securities as a result of any advertisement, article,
notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over
television or radio or presented at any seminar or any other general solicitation or general advertisement.

 

    8

     

    

 

(f) Certain
Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, the Purchaser has not, nor
has any Person acting on behalf of or pursuant to any understanding with the Purchaser, directly or indirectly executed any purchases
or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that the Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
pricing terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding
the foregoing, in the case the Purchaser is a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of the Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by
the portfolio managers managing other portions of the Purchaser’s assets, the representation set forth above shall only apply
with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities
covered by this Agreement. Other than to other Persons party to this Agreement, the Purchaser has maintained the confidentiality
of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any
actions, with respect to the identification of the availability of, or securing of, available shares to borrow in order to effect
Short Sales or similar transactions in the future.

 

(g) Access
to Information. The Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all
exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of
the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial
condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment;
and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable
effort or expense that is necessary to make an informed investment decision with respect to the investment.

 

(h) Acknowledgement
of Risk. The Purchaser acknowledges and understands that its investment in the Securities involves a significant degree of
risk, including, without limitation that (i) an investment in the Company is speculative, and only Purchaser who can afford the
loss of their entire investment should consider investing in the Company and the Securities and (ii) the Company has not paid any
dividends on its Common Stock since inception and does not anticipate the payment of dividends in the foreseeable future.

 

The Company acknowledges and agrees that
the representations contained in this Section 3.2 shall not modify, amend or affect the Purchaser’s right to rely on the
Company’s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the
consummation of the transaction contemplated hereby.

 

    9

     

    

  

ARTICLE IV.

OTHER AGREEMENTS OF THE PARTIES

 

4.1 Transfer Restrictions.

 

(a) The
Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144 or Regulation S under the Securities Act, to the Company
or to an Affiliate of the Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the
transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the
Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration of such transferred Securities under the Securities Act. As a condition of transfer, any such transferee
shall agree in writing to be bound by the terms of this Agreement and shall have the rights and obligations of the Purchaser under
this Agreement.

 

(b) The
Purchaser agrees to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following
form:

 

THESE SECURITIES REPRESENTED BY THIS CERTIFICATE
(THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).
THE SECURITIES WERE ISSUED IN A TRANSACTION EXEMPT FROM THE REGISTRATION REDISTRICTIREMENTS OF THE SECURITIES ACT PURSUANT TO REGULATION
S PROMULGATED UNDER IT. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE UNITED STATES UNLESS REGISTERED
UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR THE COMPANY SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT
REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT IS NOT REDISTRICTIRED. FURTHER, HEDGING TRANSACTIONS WITH REGARD TO THE
SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.

 

4.2 Furnishing
of Information; Public Information. Until the time that the Purchaser does not own any Securities, the Company covenants to
maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date
hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.

 

4.3 Integration.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined
in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require
the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the
Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior
to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.

 

4.4 Securities
Laws Disclosure; Publicity. The Company shall file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time as required by the Exchange Act. From and after the filing of such Current Report
on Form 8-K, the Company represents to the Purchaser that it shall have publicly disclosed all material, non-public information
delivered to any of the Purchaser by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees
or agents in connection with the transactions contemplated by the Transaction Documents. The Company and the Purchaser shall consult
with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company
nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of
the Company, with respect to any press release of any Purchaser, or without the prior consent of the Purchaser, with respect to
any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required
by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or
communication.

 

    10

     

    

 

4.5 Shareholder
Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any
Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company,
or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities
under the Transaction Documents or under any other agreement between the Company and the Purchaser.

 

4.6 Use of Proceeds.
The Company shall use the net proceeds from the sale of the Securities in accordance with the schedule agreed to by the parties.

 

4.7 Reservation
of Common Stock. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available
at all times, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to
this Agreement.

 

4.8 Listing of
Common Stock. During the term of 5 years after the closing of this transaction, the Company hereby agrees to use commercially
reasonable efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed,
and concurrently with each Closing, the Company shall apply to list or quote all of the Shares on such Trading Market and take
all reasonable actions to secure the listing of all of the Shares on such Trading Market. The Company will then take all action
reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects
with the Company’s reporting, filing and other obligations under the bylaws or rules of the Trading Market.

 

4.9 Certain Transactions
and Confidentiality. The Purchaser covenants that neither it nor any Affiliate acting on its behalf or pursuant to any understanding
with it will execute any purchases or sales, including Short Sales of any of the Company’s securities during the period commencing
with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly
announced pursuant to the initial press release as described in Section 4.4. The Purchaser covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, the Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information
included in the Disclosure Schedules.

 

4.10 Blue Sky Filings.
The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for,
or to qualify the Securities for, sale to the Purchaser at the Closing under applicable securities or “Blue Sky” laws
of the states of the United States, and shall provide evidence of such actions promptly upon request of the Purchaser.

 

ARTICLE V.

MISCELLANEOUS

 

5.1 Termination.
This Agreement may be terminated by any Purchaser or by the Company with respect to any Purchaser, as to the Purchaser’s
obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchaser, by
written notice to the other parties, if the Closing has not been consummated on or before April 30, 2021; provided, however,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).

 

5.2 Fees and Expenses.
Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation,
any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchaser.

 

    11

     

    

 

5.3 Entire Agreement.
The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with
respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

5.4 Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number or email attachment as set forth on the signature pages attached hereto at or prior to 5:30
p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or email attachment as set forth on the signature pages attached hereto on a
day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd)
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt
by the party to whom such notice is required to be given. 

 

5.5 Amendments;
Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed,
in the case of an amendment, by the Company and the Purchaser or, in the case of a waiver, by the party against whom enforcement
of any such waived provision is sought. No waiver of any default with respect to any provision, condition or requirement of this
Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any
manner impair the exercise of any such right.

 

5.6 Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.

 

5.7 Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
the Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
the Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to
the transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchaser.”

 

5.8 No Third-Party
Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted
assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

5.9 Governing Law.
All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of
conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense
of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper
or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents
to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight
delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action,
suit or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company
under Section 4.8, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable
attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action
or proceeding.

 

    12

     

    

 

5.10 Survival.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.

 

5.11 Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being
understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof.

 

5.12 Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.

 

5.13 Replacement
of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or
in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory
to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall
also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.

 

5.14 Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of
the Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation
the defense that a remedy at law would be adequate.

 

5.15 Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or
granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.

 

5.16 Construction.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting
party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and
every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after
the date of this Agreement.

 

5.17 WAIVER
OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 

(Signature Page Follows)

 

    13

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

  

	 	The Company:
	 	 
	 	CHINA GREEN AGRICULTURE, INC.
	 	 
	 	By:	/s/
	 	 	Name:
	 	 	Title:
	 	 
	 	The Purchaser
	 	 
	 	By:	/s/
	 	 	Name:
	 	 	Title:

 

    14

     

    

  

Disclosure Schedules

 

NON U.S. PERSON REPRESENTATIONS

 

The Purchaser indicating that it is not a U.S. person, severally
and not jointly, further represents and warrants to the Company as follows:

 

	 	1.	At the time of (a) the offer by the Company and (b) the acceptance of the offer by such person or entity, of the Shares, such person or entity was outside the United States.

 

	 	2.	Such person or entity is acquiring the Shares for such Shareholder’s own account, for investment and not for distribution or resale to others and is not purchasing the Shares for the account or benefit of any U.S. person, or with a view towards distribution to any U.S. person, in violation of the registration requirements of the Securities Act.

 

	 	3.	Such person or entity will make all subsequent offers and sales of the Shares either (x) outside of the United States in compliance with Regulation S; (y) pursuant to a registration under the Securities Act; or (z) pursuant to an available exemption from registration under the Securities Act. Specifically, such person or entity will not resell the Shares to any U.S. person or within the United States prior to the expiration of a period commencing on the Closing Date and ending on the date that is one year thereafter (the “Distribution Compliance Period”), except pursuant to registration under the Securities Act or an exemption from registration under the Securities Act.

 

	 	4.	Such person or entity has no present plan or intention to sell the Shares in the United States or to a U.S. person at any predetermined time, has made no predetermined arrangements to sell the Shares and is not acting as a Distributor of such securities.

 

	 	5.	Neither such person or entity, its Affiliates nor any Person acting on behalf of such person or entity, has entered into, has the intention of entering into, or will enter into any put option, short position or other similar instrument or position in the U.S. with respect to the Shares at any time after the Closing Date through the Distribution Compliance Period except in compliance with the Securities Act.

 

	 	6.	Such person or entity consents to the placement of a legend on any certificate or other document evidencing the Shares substantially in the form set forth in Section 4.1.

 

	 	7.	Such person or entity is not acquiring the Shares in a transaction (or an element of a series of transactions) that is part of any plan or scheme to evade the registration provisions of the Securities Act.

 

	 	8.	Such person or entity has sufficient knowledge and experience in finance, securities, investments and other business matters to be able to protect such person’s or entity’s interests in connection with the transactions contemplated by this Agreement.

 

    15

     

    

  

	 	9.	Such person or entity has consulted, to the extent that it has deemed necessary, with its tax, legal, accounting and financial advisors concerning its investment in the Shares.

 

	 	10.	Such person or entity understands the various risks of an investment in the Shares and can afford to bear such risks for an indefinite period of time, including, without limitation, the risk of losing its entire investment in the Shares.

 

	 	11.	Such person or entity has had access to the Company’s publicly filed reports with the SEC and has been furnished during the course of the transactions contemplated by this Agreement with all other public information regarding the Company that such person or entity has requested and all such public information is sufficient for such person or entity to evaluate the risks of investing in the Shares.

 

	 	12.	Such person or entity has been afforded the opportunity to ask questions of and receive answers concerning the Company and the terms and conditions of the issuance of the Shares.

 

	 	13.	Such person or entity is not relying on any representations and warranties concerning the Company made by the Company or any officer, employee or agent of the Company, other than those contained in this Agreement.

 

	 	14.	Such person or entity will not sell or otherwise transfer the Shares unless either (A) the transfer of such securities is registered under the Securities Act or (B) an exemption from registration of such securities is available.

 

	 	15.	Such person or entity understands and acknowledges that the Shares have not been recommended by any federal or state securities commission or regulatory authority, that the foregoing authorities have not confirmed the accuracy or determined the adequacy of any information concerning the Company that has been supplied to such person or entity and that any representation to the contrary is a criminal offense.

 

The Purchaser:

 

By: ___________________

 

	No.	 	 	Shares	 	 	Name
	 	1	 	 	 	317,500	 	 	Beijing Chengjin Investment Group Co., Ltd
	 	2	 	 	 	254,000	 	 	Shaanxi Honkwan Danton Business Partnership
	 	3	 	 	 	285,500	 	 	DiversiTech Enterprise (Xian) L.P.
	 	4	 	 	 	254,000	 	 	Shaanxi Fanta S.T.K. Mgmt L.P.
	 	5	 	 	 	317,500	 	 	Jingxiang Metro Modern Technology Co., Ltd

	 	6	 	 	 	254,000	 	 	Shensi Grechen Tinschine Partnership
	 	7	 	 	 	317,500	 	 	Great Fort Venture Fund Xa I., LP
	 	Total	 	 	 	2,000,000	 	 	 

 

 

16Exhibit10.1

 

DEED OF AMENDMENT

Dated: 1 April 2021

Between:

 

		(1)	Citibank Europe plc (the “Bank”);

 

		(2)	AXIS Specialty Limited (“ASL”);

 

		(3)	AXIS Re SE (formerly, AXIS Re Limited) (“AXIS Re”);

 

		(4)	AXIS Specialty Europe SE (formerly, AXIS Specialty Europe Limited) (“ASE”);

 

		(5)	AXIS Insurance Company;

 

		(6)	AXIS Surplus Insurance Company; and

 

		(7)	AXIS Reinsurance Company,

 

(each a “Party” and together
the “Parties”, and Parties (2), (3), (4), (5), (6) and (7) each a “Company” and together the “Companies”).

 

Re: Committed Letter of Credit Facility letter
dated 18 December 2015 and entered into among the Bank and the Companies, as amended on 24 December 2019 (the “Committed Facility
Number 1 Letter”)

 

		1.	Background

 

		1.1.	The Parties have entered into the Committed Facility Number 1 Letter in connection with the Insurance
Letters of Credit – Master Agreement (Form 3/CEP) dated 14 May 2010.

 

		1.2.	The Parties hereby agree to certain further amendments to the Committed Facility Number 1 Letter as detailed
in this Deed on and from the Effective Date (as defined below).

 

		1.3.	The terms and expressions defined in the Committed Facility Number 1 Letter shall have the same meanings
when used in this Deed unless otherwise indicated.

 

		2.	Effective Date

 

The amendments set out in this Deed
shall take effect on and from 31 March 2021 (“Effective Date”).

 

    1

     

    

 

		3.	Amendments

 

		3.1.	With effect on and from the Effective Date, the Committed Facility Number 1 Letter shall be amended as
follows:

 

		(a)	clause 3 (Facility Documents) shall be deleted and replaced with the follows:

 

“The Companies (as indicated
below) have entered into or shall enter into the following documents in relation to the Facility:

 

		(a)	Insurance Letters of Credit – Master Agreement (Form 3/CEP) dated 14 May 2010 entered into between
the Bank and the Companies (the “Master Agreement”);

 

		(b)	Amended and Restated Pledge Agreement dated on or about the date of the Deed of Amendment Date and
entered into between ASL and the Bank, which amends and restates the Pledge Agreement between ASL and the Bank dated 14 May 2010 (the
“ASL Pledge Agreement”);

 

		(c)	Collateral Account Control Agreement dated 19 May 2015 entered into between ASL, The Bank of New York
Mellon (the “Securities Intermediary”) and the Bank;

 

		(d)	Pledge Agreement dated on or about the Deed of Amendment Date entered into between AXIS Re and the
Bank (the “AXIS Re Pledge Agreement”);

 

		(e)	Collateral Account Control Agreement dated on or about the Deed of Amendment Date entered into among
AXIS Re, the Bank and the Securities Intermediary;

 

		(f)	Pledge Agreement dated on or about the Deed of Amendment Date entered into between ASE and the Bank
(the “ASE Pledge Agreement”);

 

		(g)	Collateral Account Control Agreement dated on or about the Deed of Amendment Date entered into among
ASE, the Bank and the Securities Intermediary; and

 

		(h)	Facility Fee Letter dated 18 December 2015 entered into among the Bank and the Companies,

 

in each case, as amended or as may
be amended, varied, supplemented, novated or assigned from time to time (each a “Facility Document”, and the ASL Pledge Agreement,
the AXIS RE Pledge Agreement and the ASE Pledge Agreement each a “Pledge Agreement”). In the event of any inconsistency between
the terms of this Letter and the terms of any Facility Document, the terms of this Letter shall prevail.”;

 

		(b)	clause 5.2(d) shall be deleted and replaced with the following:

 

	 	“(d)	where
  the Company is a Company other than AXIS Re or ASE, there is a failure to deposit in a securities account with the Securities Intermediary
  a deposit in an amount required under the terms of the ASL Pledge Agreement;

 

		(e)	where the Company is AXIS Re, there is a failure to deposit in a securities account with the Securities
Intermediary a deposit in an amount required under the terms of the AXIS Re Pledge Agreement or the ASL Pledge Agreement; and/or

 

		(f)	where the Company is ASE, there is a failure to deposit in a securities account with the Securities
Intermediary a deposit in an amount required under the terms of the ASE Pledge Agreement or the ASL Pledge Agreement.”;

 

		(c)	a new clause 5.6 shall be inserted after clause 5.5 as follows:

 

“Where the Company that requested
the Credit under the Facility is either AXIS Re or ASE, it is agreed that the undertaking given clause 1.1(ii) of the Master Agreement
shall also be given by that Company in respect of such Credit, and each reference in such clause 1.1(ii) to the Pledge Agreement shall
be deemed to refer to the Pledge Agreements as defined in this Letter.”;

 

    2

     

    

 

		(d)	in clauses 6.2 and 6.3, each reference to “LIBOR” shall be replaced with “SOFR”;

 

		(e)	in clause 8(c), the words “the Pledge Agreement” shall be deleted and replaced with
“the Pledge Agreements”;

 

		(f)	in clause 13.1, the definitions of “Facility Document/Documents” and “Pledge
Agreement” shall be replaced with the following new definitions:

 

“Facility Document
means each document specified as a Facility Document in clause 3 (Facility Documents), this Letter, any
other document pursuant to which a security interest, guarantee or other form of credit support is created or exists in favour of the
Bank in respect of the obligations of the Companies under this Letter and any other document mutually designated as a Facility
Document by the Bank and the Companies.”

 

“Pledge Agreement means
each document specified as a Pledge Agreement in clause 3 (Facility Documents).”; 

 

		(g)	in clause 13.1, the definition of “LIBOR” shall be deleted and each of the following new definitions shall be inserted
in the appropriate place in alphabetical order:

 

"Affiliate means, in
relation to any person, a Subsidiary of that person or a Holding Company of that person or any other Subsidiary of that Holding Company.”

 

“Code means the US
Internal Revenue Code of 1986.”

 

“Correspondent means,
in relation to a Credit, a third party correspondent which has issued or, as the context requires, it is proposed will issue that Credit
at the request of the Bank.”

 

“Deed of Amendment Date
means the date of the deed of amendment entered into between the Bank and the Companies in respect of this Letter on or around 31 March
2021.”

 

“FATCA means (a) sections
1471 to 1474 of the Code or any associated regulations or other official guidance (b) any treaty, law, regulation or other official guidance
enacted in any other jurisdiction, or relating to an intergovernmental agreement between the US and any other jurisdiction, which (in
either case) facilitates the implementation of paragraph (a) above or (c) any agreement pursuant to the implementation of paragraphs (a)
or (b) above with the US Internal Revenue Service, the US government or any governmental or taxation authority in any other jurisdiction.”

 

“FATCA Deduction means
a deduction or withholding from a payment under a Facility Document required by FATCA.”

 

“Finance Party means
the Bank and any Correspondent which issues a Payment Instrument.”

 

"Holding Company means,
in relation to a company or corporation, any other company or corporation in respect of which it is a Subsidiary.”

 

    3

     

    

 

“Increased Cost means:

 

(a)       a
reduction in the rate of return from the Facility or on the overall capital of the Bank or any of its Affiliates;

 

(b)       an
additional or increased cost; or

 

(c)       a
reduction of any amount due and payable under the Facility, which is incurred or suffered by the Bank or any of its Affiliates to
the extent that it is attributable to the Bank funding or performing its obligations under the Facility.”

 

“SOFR means, with respect
to any Business Day, a rate per annum equal to the secured overnight financing rate for such Business Day published by the SOFR Administrator
on the SOFR Administrator’s Website on the immediately succeeding Business Day.”

 

"Subsidiary means a
subsidiary within the meaning of section 1159 of the Companies Act 2006, and for this purpose if any shares are held by way of security,
the person providing that security shall be treated as the member of the relevant company unless and until that security is realised,
notwithstanding that the beneficiary of that security (or a nominee of that beneficiary) may be registered as a member of the relevant
company.”

 

“Tax means any tax,
levy, impost, duty or other charge or withholding of a similar nature (including any penalty or interest payable in connection with any
failure to pay or any delay in paying any of the same).”

 

“Tax Deduction means
a deduction or withholding for or on account of Tax from a payment under a Facility Document.”; 

 

"Irish Qualifying Lender"
means a Finance Party which is beneficially entitled to interest payable in respect of an advance under a Facility Document and is:

 

		i.	a bank, within the meaning of section 246(1) TCA which is carrying on a bona fide banking business
in Ireland for the purposes of section 246(3)(a) TCA; or

 

		ii.	a body corporate:

 

		(A)	which is resident for the purposes of tax in a Relevant Territory (residence for these purposes is
to be determined in accordance with the laws of the Relevant Territory of which the Finance Party claims to be resident) where that Relevant
Territory imposes a tax that generally applies to interest receivable in that Relevant Territory by bodies corporate from sources outside
that Relevant Territory; or

 

		(B)	where interest payable under a Facility Document:

 

		(aa)	is exempted from the charge to income tax under a Treaty in force between Ireland and the country in
which the Finance Party is resident for tax purposes; or

 

		(bb)	would be exempted from the charge to income tax under a Treaty signed between Ireland and the country
in which the Finance Party is resident for tax purposes if such Treaty had the force of law by virtue of section 826(1) TCA; 

 

    4

     

    

 

except where interest is paid under
a Facility Document to the body corporate in connection with a trade or business which is carried on by it in Ireland through a branch
or agency; or

 

		iii.	a company that is incorporated in the US and taxed in the US on its worldwide income except where interest
is paid under a Facility Document to the US company in connection with a trade or business which is carried on by it in Ireland through
a branch or agency; or

 

		iv.	a US limited liability company (“LLC”), where the ultimate recipients of the interest payable
under a Facility Document are Irish Qualifying Lenders within paragraphs (ii) or (iii) of this definition and the business conducted through
the LLC is so structured for market reasons and not for tax avoidance purposes except where interest is paid under a Facility Document
to the LLC in connection with a trade or business which is carried on by it or them in Ireland through a branch or agency; or

 

		v.	a qualifying company within the meaning of section 110 TCA; or

 

		vi.	an exempt approved scheme within the meaning of section 774 TCA; or

 

		vii.	an investment undertaking within the meaning of section 739B TCA; or

 

		viii.	a body corporate:

 

		(a)	which advances money in the ordinary course of a trade which includes the lending of money; and

 

		(b)	where interest on an advance under a Facility Document is taken into account in computing the trading
income of such body corporate; and

 

		(c)	which has made the appropriate notifications under section 246(5)(a) TCA to the Irish Revenue Commissioners
and the relevant Company; or

 

		ix.	an Irish Treaty Lender 

 

"Relevant Territory"
means: 

 

		(i)	a member state of the European Union (other than Ireland); or 

 

		(ii)	not being such a member state, a country with which Ireland has a Treaty in force by virtue of section
826(1) TCA; or 

 

		(iii)	not being a territory referred to in (i) or (ii) above, a country with which Ireland has signed such
a Treaty which will come into force once the procedures set out in section 826(1) TCA have been completed.

 

"TCA"
means the Taxes Consolidation Act of Ireland, 1997; 

 

    5

     

    

 

"Irish Treaty Lender"
means a Finance Party which:

 

		(i)	does not fall within parts (ii), (iii) or (iv) of the Irish Qualifying
Lender definition and is treated as a resident of an Irish Treaty State for the purposes of the Treaty; and

 

		(ii)	does not carry on a business in Ireland through a permanent establishment
with which that Finance Party's participation in a Facility Document is effectively connected; and

 

		(iii)	is, subject to the completion of procedural formalities, entitled to
a full exemption from Irish tax on interest payable to that Finance Party in respect of an advance under a Finance Document.

 

"Irish Treaty State"
means a jurisdiction having a double taxation agreement (a "Treaty") with Ireland which makes provision for full exemption
from tax imposed by Ireland on interest; and

 

		(h)	the following new clauses 16 and 17 shall be inserted after clause 15 (being the clause titled “15.
Data Protection” inserted by the amendment dated 24 December 2019):

 

		“16	Recognition of bail-in

 

		16.1	Notwithstanding any other terms of this Letter, any other Facility Document or any other agreement,
arrangement or understanding between the parties, each counterparty (including the Companies) to a BRRD Party acknowledges and accepts
that any liability of a BRRD Party to it under or in connection with this Letter and any other Facility Document may be subject to Bail-In
Action by the relevant Resolution Authority and acknowledges and accepts to be bound by the effect of: (i) any Bail-In Action in
relation to any such liability, including (without limitation) (A) a reduction, in full or in part, in the principal amount, or outstanding
amount due (including any accrued but unpaid interest) in respect of any such liability, (B) a conversion of all, or part of, any
such liability into shares or other instruments of ownership that may be issued to, or conferred on, it and (C) a cancellation of
any such liability; and (ii) a variation of any terms of this Letter or any other Facility Document to the extent necessary to give
effect to any Bail-In Action in relation to any such liability.

 

		16.2	For the purposes of this clause 16 (Recognition of Bail-In): (i) "Bail-In Action" means the exercise of any Write-down and Conversion Powers; (ii) "Bail-In Legislation" means, in relation to Ireland, the European Union (Bank Recovery and Resolution) Regulations 2015 (S.I. No. 289/2015); (iii) "BRRD" means Directive 2014/59/EU establishing a framework for the recovery and resolution of credit institutions and investment firms; (iv) "BRRD Party" means an institution or entity referred to in point (b), (c) or (d) of Article 1(1) BRRD, including Citibank Europe plc; (v) "EEA Member Country" means any member state of the European Union, Iceland, Liechtenstein and Norway; (vi) "Resolution Authority" means anybody which has authority to exercise any Write-down and Conversion Powers; and (vii) "Write-down and Conversion Powers" means, in relation to Ireland, any write-down, conversion, transfer, modification or suspension power existing from time to time under, and exercised in compliance with, any law or regulation in effect in Ireland, relating to the transposition of Directive 2014/59/EU establishing a framework for the recovery and resolution of credit institutions and investment firms, including but not limited to the Bail-In Legislation and Regulation (EU) No  806/2014 and the instruments, rules and standards created thereunder, pursuant to which (A) any obligation of a bank or investment firm or affiliate of a bank or investment firm can be reduced, cancelled, modified or converted into shares, other securities or other obligations of such entity or any other person (or suspended for a temporary period) and (B) any right in a contract governing an obligation of a bank or investment firm or affiliate of a bank or investment firm may be deemed to have been exercised.

 

    6

     

    

 

		17	Tax: Increased Costs

 

		17.1	Tax gross-up: (a) The Company shall make all necessary payments without any Tax Deduction,
unless a Tax Deduction is required by law. (b) The Company shall promptly upon becoming aware it must make a Tax Deduction (or that there
is any change in the rate or the basis of a Tax Deduction) notify the Bank accordingly. (c) If a Tax Deduction is required by law to be
made by the Company, the amount of the payment due from the Company shall be increased to an amount which (after making any Tax Deduction)
leaves an amount equal to the payment which would have been due if no Tax Deduction had been required, subject to the Bank providing the
Company with any documentation and/or information requested by the Company to determine applicable Tax Deduction. (d) If the Company is
required to make a Tax Deduction, the Company shall make that Tax Deduction and any payment required in connection with that Tax Deduction
within the time allowed and in the minimum amount required by law. (e) Within 30 days of making either a Tax Deduction or any payment
required in connection with that Tax Deduction, the Company shall deliver to the Bank evidence reasonably satisfactory to the Bank that
the Tax Deduction has been made or (as applicable) any appropriate payment paid to the relevant taxing authority.

 

		17.2	(a)     A payment shall not be increased under Clause 17.1 by reason of a Tax Deduction on account of
Tax imposed by Ireland if on the date on which the payment falls due:

 

 

		(i)	the payment could have been made to the Bank without a Tax Deduction if the Bank had been an Irish
Qualifying Lender, but on that date that Bank is not or has ceased to be an Irish Qualifying Lender other than as a result of any change
after the date it became a Finance Party under a Facility Document in (or in the interpretation, administration, or application of) any
law or Treaty, or any published practice or published concession of any relevant taxing authority; or

 

		(ii)	the Bank is an Irish Treaty Lender and the relevant Company is able to demonstrate that the payment
could have been made to the Bank without the Tax Deduction had the Bank complied with its obligations under paragraph (b) below. 

 

		(b)	An Irish Treaty Lender and the Company which makes a payment to which that Irish Treaty Lender is entitled
shall co-operate in completing any procedural formalities necessary for the Company to obtain authorisation to make that payment without
a Tax Deduction.

 

		(c)	The Bank confirms that, on the Effective Date, it is an Irish Qualifying Lender.

 

    7

     

    

 

		17.3	Tax indemnity

 

		(a)	The Company shall (within three Business Days of demand by the Bank) pay to the Bank an amount equal
to any loss, liability or cost which the Bank determines will be or has been (directly or indirectly) suffered for or on account of Tax
by the Bank in respect of any Facility Document.

 

		(b)	Paragraph (a) above shall not apply:

 

		(i)	with respect to any Tax assessed on the Bank:

 

		1)	under the law of the jurisdiction in which the Bank is incorporated or, if different, the jurisdiction
(or jurisdictions) in which the Bank is treated as resident for tax purposes; or

 

		2)	under the law of the jurisdiction in which the Bank's facility office is located in respect of amounts
received or receivable in that jurisdiction,

 

if that Tax is imposed on or calculated
by reference to the net income received or receivable (but not any sum deemed to be received or receivable) by the Bank; or

 

		(ii)	to the extent a loss, liability or cost is compensated for by an increased payment under clause 17.1
(Tax gross-up); or

 

		(iii)	would have been compensated for by an increased payment under clause ‎17.1 (Tax gross-Up) but
was not so compensated solely because one of the exclusions in clause ‎17.2(a) applied; or

		(iv)	relates to a FATCA Deduction required to be made by a Party.

 

		17.4	Stamp taxes: The Company shall (within three Business Days of demand by the Bank) pay
to the Bank an amount equal to any cost, loss or liability the Bank incurs in relation to all stamp duty, registration and other similar
Taxes payable in respect of any Facility Document.

 

		17.5	VAT: All amounts expressed to be payable by the Company under any Facility Document shall
be deemed to be exclusive of any value added tax, goods and services tax or similar tax, and if any such tax is or becomes chargeable
on any supply made by to the Company under any Facility Document, the Company shall pay to the Bank (in addition to the consideration
for such supply) an amount equal to the amount of such tax.

 

		17.6	Increased costs: Subject to clause 17.7 (Exceptions) the Company shall, within three
Business Days of a demand by the Bank, pay the Bank the amount of any Increased Costs incurred by the Bank or any of its Affiliates as
a result of:

 

		(a)	the introduction of or any change in (or in the interpretation, administration or application of) any
law or regulation; or

 

    8

     

    

 

		(b)	compliance with any law or regulation,

 

made after the date of this Agreement.

 

		17.7	Exceptions: Clause 17.6 (Increased costs) does not apply to the extent any Increased
Cost is (a) attributable to a Tax Deduction required by law to be made by the Company, (b) compensated for by clause 17.3 (Tax indemnity)
(or would have been compensated for under clause 17.3 (Tax indemnity) but was not so compensated solely because any of the exclusions
in clause 17.3(b) (Tax indemnity) applied), or (c) attributable to the wilful breach by the relevant Finance Party or its Affiliates of
any law or regulation.

 

		17.8	FATCA Deduction:

 

		(a)	Each Finance Party may make any FATCA Deduction it is required by FATCA to make, and any payment required
in connection with that FATCA Deduction, and no Finance Party shall be required to increase any payment in respect of which it makes such
a FATCA Deduction or otherwise compensate the recipient of the payment for that FATCA Deduction. A Finance Party which becomes aware that
it must make a FATCA Deduction in respect of a payment to another party (or that there is any change in the rate or the basis of such
FATCA Deduction) shall provide prompt notification to that party and the Bank.

 

		(b)	The Company shall (within three Business Days of demand) pay to a Finance Party an amount equal to
the loss, liability or cost which that Finance Party determines will be or has been (directly or indirectly) suffered by that Finance
Party as a result of another Finance Party making a FATCA Deduction in respect of a payment due to it under a Facility Document. This
paragraph (b) shall not apply to the extent a loss, liability or cost is compensated for by an increased payment under clause 17.2 or
paragraph(a) above.

 

		(c)	A Finance Party making, or intending to make, a claim under paragraph (b) above shall promptly notify
the Company.”.

 

		3.2.	The Parties agree that, with effect on and from the Effective Date, the courts of England have exclusive
jurisdiction to settle any dispute arising out of or in connection with the Master Agreement and/or the Committed Facility Number 1 Letter.
The Parties agree that the courts of England are the most appropriate and convenient courts to settle any such dispute and, accordingly,
that they will not argue to the contrary. The provisions of this paragraph 3.2 shall, to the extent of any inconsistency, supersede the
choice of jurisdiction provided for in clause 12 (Governing Law/Jurisdiction) of the Master Agreement and clause 14.1 (Governing
Law) of the Committed Facility Number 1 Letter.

 

		4.	Costs and expenses

 

Each Party to this Deed shall bear
its own costs and expenses in relation to the amendments agreed pursuant to the terms of this Deed.

 

		5.	Affirmation and acceptance

 

		5.1.	With effect from the Effective Date, the terms and conditions of the Committed Facility Number 1 Letter
shall be read and construed by reference to this Deed and all references to the Committed Facility Number 1 Letter shall be
deemed to incorporate the relevant amendments contained within this Deed and all references in the Committed Facility Number 1 Letter
to “this Letter” and like references shall with effect from the Effective Date be references to the Committed Facility Number
1 Letter as amended by this Deed.

 

    9

     

    

 

		5.2.	In the event of any conflict between the terms of this Deed and this Committed Facility Number 1 Letter,
the terms of this Deed shall prevail.

 

		5.3.	For the avoidance of doubt, except as amended by the terms of this Deed, all of the terms and conditions
of the Committed Facility Number 1 Letter shall continue to apply and remain in full force and effect.

 

		5.4.	The Companies shall, at the request of Bank, do all such acts necessary or desirable to give effect to
the amendments effected or to be effected pursuant to the terms of this Deed.

 

		6.	Continuation of the Facility Documents

 

The Parties agree that, on and after
the Effective Date:

 

		(a)	each Facility Document (as defined in the Committed Facility Number 1 Letter as amended by this Deed)
to which it is a party shall continue in full force and effect; and

 

		(b)	each Pledge Agreement (as defined in the Committed Facility Number 1 Letter as amended by this Deed) to
which it is a party shall continue to secure all liabilities which are expressed to be secured by it, and any security pledged thereunder
shall extend to the Committed Facility Number 1 Letter, as amended pursuant to this Deed.

 

		7.	Facility Document

 

The Parties designate this Deed as
a Facility Document.

 

		8.	Counterparts and effect as a deed

 

This Deed may be executed in counterparts,
each of which shall be deemed to be an original, and all such counterparts taken together shall constitute one and the same agreement.
This amendment shall take effect as a Deed notwithstanding it is signed under hand by Bank.

 

		9.	Third party rights

 

No person shall have any right to
enforce any provision of this Deed under the Contracts (Rights of Third Parties) Act 1999.

 

		10.	Governing law

 

This Deed (and any non-contractual
obligation, dispute, controversy, proceedings or claim of whatever nature arising out of it or in any way relating to this Deed or its
formation) shall be governed by and construed in accordance with English law. The Parties irrevocably submit the jurisdiction of the English
Courts in respect of any dispute which may arise from or in connection with this Deed.

 

This Deed has been executed and delivered by
the Companies as a deed and it has been signed by the Bank under hand, and shall take effect on and from the date specified above.

 

[Signatures follow]

 

    10

     

    

 

Signatories to the Deed of Amendment

 

	Executed
    and delivered as a deed by AXIS Specialty	Signed: 	 /s/ Peter J. Vogt
	Limited	Name:	 Peter J. Vogt
	Acting
    by a director	Title	Director

 

	In
    the presence of	 
	 	Signature of Witness: 	 /s/ Nancy Vogt
	 	Name of Witness: 	Nancy Vogt
	 	Address: 	[Address]

 

	Executed
    and delivered as a deed by AXIS Re SE (formerly	Signed:  	/s/ Tim Hennessy
	AXIS
    Re Limited)	Name: 	Tim Hennessy
	Acting
    by a director	Title	Director

 

	In
    the presence of	 
	 	Signature of Witness: 	 /s/ Sheena Hennessy
	 	Name of Witness: 	Sheena Hennessy
	 	Address: 	[Address]

 

	Executed
    and delivered as a deed by AXIS Specialty	Signed:  	/s/ Tim Hennessy
	Europe
    SE (formerly, AXIS Specialty Europe Limited)	Name:	 Tim Hennessy
	Acting
    by a director	Title	Director

 

	In
    the presence of	 
	 	Signature of Witness:  	/s/ Sheena Hennessy
	 	Name of Witness: 	Sheena Hennessy
	 	Address: 	[Address]

 

	Executed
    and delivered as a deed by AXIS Insurance	Signed: 	 /s/ Andrew M. Weissert
	Company	Name: 	Andrew M. Weissert
	Acting
    by a director	Title	Director

 

	In
    the presence of	 
	 	Signature of Witness:  	/s/ Brenda Reese
	 	Name of Witness: 	Brenda Reese
	 	Address: 	[Address]

 

    11

     

    

 

	Executed
    and delivered as a deed by AXIS Surplus	Signed:  	/s/ Andrew M. Weissert
	Insurance
    Company	Name: 	Andrew M. Weissert
	Acting
    by a director	Title 	Director

 

	In
    the presence of	 
	 	Signature of Witness:  	/s/ Brenda Reese
	 	Name of Witness: 	Brenda Reese
	 	Address: 	[Address]

 

	Executed
    and delivered as a deed by AXIS Reinsurance	Signed:  	/s/ Andrew M. Weissert
	Company	Name: 	Andrew M. Weissert
	Acting
    by a director	Title 	Director

 

	In
    the presence of	 
	 	Signature of Witness:	 /s/ Brenda Reese
	 	Name of Witness:	 Brenda Reese
	 	Address: 	[Address]

 

WE HEREBY CONFIRM OUR ACCEPTANCE ON BEHALF OF BANK:

 

For and on behalf of

Citibank Europe Plc

 

	By: 	/s/ Niall Tuckey	 
	Name:  	Niall Tuckey	 
	Title: 	Director	 

 

    12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]